Profile data is unavailable for this security.
About the company
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients.
- Revenue in USD (TTM)22.25m
- Net income in USD-49.97m
- Incorporated--
- Employees320.00
- LocationPrenetics Global LtdUnit 701-706, K11 Atelier King's Road,728 King's Road, Quarry Bay Hong KongHKG
- Phone+852 22109588
- Websitehttps://ir.prenetics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Syros Pharmaceuticals Inc | 4.15m | -131.56m | 53.08m | 68.00 | -- | -- | -- | 12.80 | -4.30 | -4.30 | 0.1222 | -0.2369 | 0.0288 | -- | -- | 61,000.00 | -91.46 | -54.44 | -112.06 | -64.32 | -- | -- | -3,171.70 | -772.82 | -- | -- | 1.18 | -- | -33.23 | 37.12 | -73.87 | -- | -27.78 | -- |
| Serina Therapeutics Inc | 179.00k | -18.67m | 53.38m | 4.00 | -- | -- | -- | 298.20 | -9.72 | -9.72 | 0.0403 | -1.86 | 0.0156 | -- | 6.28 | 44,750.00 | -162.58 | -194.46 | -- | -- | 49.72 | 85.80 | -10,438.55 | -2,347.36 | -- | -1.82 | -- | -- | 317.65 | -36.69 | -41.49 | -- | -- | -- |
| Angion Biomedica Corp | 0.00 | -38.66m | 54.84m | 32.00 | -- | -- | -- | -- | -4.83 | -4.83 | 0.00 | -0.161 | 0.00 | -- | -- | 0.00 | -144.89 | -105.91 | -202.49 | -331.69 | -- | -- | -- | -712.81 | -- | -- | -- | -- | -100.00 | -- | 9.31 | -- | -- | -- |
| Aerovate Therapeutics Inc | 0.00 | -87.94m | 55.14m | 51.00 | -- | 0.5838 | -- | -- | -3.14 | -3.14 | 0.00 | 3.27 | 0.00 | -- | -- | 0.00 | -65.76 | -- | -74.16 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -46.61 | -- | -- | -- |
| Prenetics Global Ltd | 22.25m | -49.97m | 55.28m | 320.00 | -- | 0.2413 | -- | 2.48 | -4.33 | -5.32 | 1.91 | 18.75 | 0.0832 | 3.89 | 4.53 | 69,535.41 | -19.43 | -- | -23.55 | -- | 45.56 | -- | -233.41 | -- | 2.25 | -5.17 | 0.0086 | -- | 65.17 | -- | 75.91 | -- | -- | -- |
| Actinium Pharmaceuticals Inc | 81.00k | -42.62m | 55.45m | 49.00 | -- | 1.24 | -- | 684.63 | -1.52 | -1.52 | 0.0029 | 1.43 | 0.0009 | -- | -- | 1,653.06 | -45.12 | -46.98 | -50.13 | -52.71 | -- | -- | -52,620.99 | -6,683.95 | -- | -- | 0.0006 | -- | -92.14 | -- | -47.86 | -- | 9.75 | -- |
| Kronos Bio Inc | 8.41m | -102.85m | 55.48m | 58.00 | -- | 0.4503 | -- | 6.60 | -1.75 | -1.75 | 0.1425 | 2.04 | 0.0396 | -- | -- | 135,661.30 | -48.41 | -35.47 | -53.26 | -37.14 | -- | -- | -1,222.83 | -7,975.76 | -- | -- | 0.00 | -- | -- | -- | 15.41 | -- | -8.78 | -- |
| Hookipa Pharma Inc | 52.16m | -48.60m | 55.69m | 151.00 | -- | 0.6471 | -- | 1.07 | -5.28 | -5.28 | 4.85 | 7.14 | 0.33 | -- | 309.57 | 345,450.30 | -30.74 | -41.63 | -40.15 | -50.26 | -- | -- | -93.16 | -366.65 | -- | -- | 0.00 | -- | 41.27 | 21.41 | -25.67 | -- | 14.11 | -- |
| Celularity Inc | 22.77m | -196.30m | 56.28m | 120.00 | -- | 1.21 | -- | 2.47 | -11.29 | -11.29 | 1.30 | 2.11 | 0.0836 | 2.90 | 2.39 | 189,758.30 | -72.04 | -19.19 | -94.47 | -20.99 | 29.66 | -- | -862.04 | -454.79 | 0.2086 | 1.37 | 0.4893 | -- | 26.68 | -- | -1,483.14 | -- | -- | -- |
| VolitionRX Ltd | 976.52k | -32.42m | 56.57m | 110.00 | -- | -- | -- | 57.93 | -0.4032 | -0.4032 | 0.0121 | -0.263 | 0.0481 | -- | 5.38 | 8,877.45 | -161.39 | -111.92 | -- | -196.20 | -- | -- | -3,357.34 | -10,793.31 | -- | -129.66 | -- | -- | 153.04 | -- | -16.68 | -- | 29.13 | -- |
| Enzo Biochem Inc | 33.34m | -17.55m | 57.12m | 179.00 | -- | 0.8237 | -- | 1.71 | -0.3516 | 0.9194 | 0.6633 | 1.35 | 0.4028 | 1.66 | 4.91 | 186,257.00 | -21.20 | -12.21 | -34.50 | -15.79 | 43.66 | 37.09 | -52.63 | -18.76 | 3.16 | -- | 0.053 | -- | -4.85 | -21.01 | -23.02 | -- | 7.89 | -- |
| Aileron Therapeutics Inc | 0.00 | -25.22m | 57.41m | 15.00 | -- | 1.02 | -- | -- | -3.25 | -3.25 | 0.00 | 4.67 | 0.00 | -- | -- | 0.00 | -40.88 | -65.99 | -43.02 | -75.37 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 42.43 | -- | -- | -- |
| Intensity Therapeutics Inc | 0.00 | -15.08m | 57.43m | 5.00 | -- | 10.70 | -- | -- | -1.10 | -1.10 | 0.00 | 0.3898 | 0.00 | -- | -- | 0.00 | -112.08 | -- | -146.09 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.45 | -- | -- | -- |
| Champions Oncology Inc | 51.66m | -3.40m | 58.18m | 210.00 | -- | -- | -- | 1.13 | -0.2541 | -0.2541 | 3.78 | -0.0244 | 1.88 | -- | 5.75 | 245,976.20 | -12.39 | -10.00 | -44.43 | -23.00 | 44.27 | 46.58 | -6.58 | -6.04 | -- | -- | 333.00 | -- | -6.90 | 13.13 | -36.38 | -- | 0.0479 | -- |
Data as of Sep 19 2024. Currency figures normalised to Prenetics Global Ltd's reporting currency: US Dollar USD
11.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Eastspring Investments (Singapore) Ltd.as of 30 Jun 2024 | 482.96k | 4.54% |
| Pacific Alliance Investment Management (HK) Ltd.as of 27 Nov 2023 | 375.29k | 3.53% |
| Nomura Securities Co., Ltd. (Private Banking)as of 30 Jun 2024 | 322.95k | 3.04% |
| UBS Securities LLCas of 30 Jun 2024 | 40.09k | 0.38% |
| Aspire Private Capital LLCas of 30 Jun 2024 | 114.00 | 0.00% |
| BofA Securities, Inc.as of 30 Jun 2024 | 111.00 | 0.00% |
| Wolverine Asset Management LLCas of 30 Jun 2024 | 1.00 | 0.00% |
More ▼
Data from 27 Nov 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
